Today on Outsourcing-Pharma.com   Preclinical presence in Asia contines to gain momentum INC Research bags lucrative development grant Contract manufacturing news in brief Meldex moves in Germany, inks new deal Foot-tapping boosts laboratory efficiency

Related Industry News   Tracking HIV evolution from birth to death Billionaire 'raider' circles as Biogen put up for sale Wyeth ups the ante with new proteomics method GSK, Synta join forces in billion dollar cancer deal

Breaking News on Outsourcing Pharma
Daily  Wednesday 17 October 2007		Forward to a colleague

	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Access Full Stories Preclinical presence in Asia contines to gain momentum The activity of local and international firms establishing preclinical testing services to good laboratory practice (GLP) standards in Asia continues to gain momentum... Read INC Research bags lucrative development grant INC has bagged local development funding that could be worth nearly $15m (€10.5m) for the firm over a number of years... Read Contract manufacturing news in brief Microbix Biosystems, PacificGMP and Insulet have all recently announced new contract manufacturing news... Read Meldex moves in Germany, inks new deal Growing demand has prompted tableting specialist Meldex International, formerly BioProgress, to launch a new sales and distribution hub in Germany, with the UK firm also announcing a new manufacturing contract... Read Foot-tapping boosts laboratory efficiency A new foot-controlled PC mouse aims to increase researchers' efficiency by removing the need for repetitive glove removal and hand washing before using laboratory computers... Read
	All News Headlines for: October | September | August
	Related Industry News Tracking HIV evolution from birth to death A group of US researchers have tracked how HIV evolves over the course of a person's lifetime and the findings could pave the way for new drugs that combat the disease before it can kill... Read Billionaire 'raider' circles as Biogen put up for sale Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read Wyeth ups the ante with new proteomics method Researchers from Wyeth Research's Biological Technologies division have described how the use of a titania-affinity enrichment step can aid in the discovery of post-translational protein modifications... Read GSK, Synta join forces in billion dollar cancer deal GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read Weekly Comment Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development. Read Previous Headlines United drug makes another services acquisition United drug has purchased another services business in what is turning out to be an acquisitive year for the ambitious Irish distributor... Read Boehringer hopes cash injection will turbocharge diabetes and obesity programme Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece of the action... Read Results: 2007 European outsourcing awards The ten winners of the European outsourcing awards for 2007 were finally unveiled at the recently-held CPhI trade show in Milan... Read Galapagos gains grants of €5.2m Galapagos and its services division BioFocus DPI have gained three new research grants totalling €5.2m... Read US dragging its heels on biosimilars, says report The US is woefully lagging behind the EU when it comes to approving biosimilars, a new report says... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com